2024-09-10 - Analysis Report
## AMGN Stock Analysis Report

**Company Overview:** Amgen is a leading global biotechnology company, specializing in the development and commercialization of innovative medicines.

**Performance Analysis:**

**1. Return Rate vs. S&P 500:**
* **AMGN Cumulative Return:** 51.95%
* **VOO (S&P 500) Cumulative Return:** 81.34%
* **Relative Performance:** -29.39% (48.09% relative to historical range)

This means AMGN has underperformed the S&P 500 by 29.39%, however, this is only 48.09% of its historical underperformance range.

**2. Recent Price Movement:**
* **Closing Price:** $320.56
* **5-Day Moving Average:** $327.98
* **20-Day Moving Average:** $326.43
* **60-Day Moving Average:** $322.86

AMGN is currently trading below its 5-day and 20-day moving averages, indicating a potential downward trend.

**3. Technical Indicators:**
* **RSI:** 48.88 (Neutral)
* **PPO:** -0.19 (Weak Trend)
* **Delta_Previous_Relative_Divergence:** -6.04 (Short-Term Downward Trend)
* **Expected Return:** 7.27% (Estimated 5-year maximum return for a lump sum investment)

RSI is neutral, suggesting no strong momentum. PPO and Delta_Previous_Relative_Divergence indicate a weak trend and short-term downward pressure.

**4. Recent Earnings and Outlook:**
* **Earnings:** 
| Date | EPS | Revenue |
|---|---|---|
| 2024-08-07 | 1.39 | 8.39 B$ |
| 2024-05-03 | -0.21 | 7.45 B$ |
| 2023-10-31 | 3.23 | 6.90 B$ |
| 2023-08-04 | 2.58 | 6.99 B$ |
| 2024-08-07 | 2.58 | 6.99 B$ |

The most recent earnings report shows a beat on EPS and revenue, with EPS coming in at $1.39, exceeding analysts' expectations. 

**Overall Analysis:**

AMGN's performance has lagged the S&P 500, indicating a period of relative underperformance. Recent price movements suggest potential downward pressure, supported by the negative Delta_Previous_Relative_Divergence and PPO indicators. However, the recent earnings report shows a positive beat on EPS and revenue, indicating a potential for future growth. Further analysis of the company's financial health, competitive landscape, and future pipeline is necessary to form a complete investment decision. 
